Lifecore Biomedical, Inc. LFCR

Company Overview

Lifecore Biomedical, Inc. (LFCR) is a U.S.-based contract development and manufacturing organization (CDMO) specializing in injectable pharmaceuticals and medical devices, with a particular focus on products formulated with hyaluronic acid (HA). The company operates at the intersection of biopharmaceutical manufacturing, medical aesthetics, and orthopedic and ophthalmic therapies, providing development, fill-finish, and commercial-scale manufacturing services. Lifecore’s primary revenue is generated through long-term manufacturing contracts and development services for regulated pharmaceutical and medical device customers.

The company is recognized for its specialized expertise in HA-based formulations, sterile injectables, and complex biologic handling, which creates switching costs and long-term customer relationships. Lifecore’s positioning is supported by vertically integrated capabilities that span formulation, aseptic filling, device assembly, and quality-controlled commercial manufacturing. The business traces its origins to the biomedical operations of Landec Corporation and became an independent publicly traded entity following a corporate separation, after which it refocused exclusively on CDMO services for injectable therapeutics.